Article
Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
Journal of molecular neuroscience : MN - 1 Jan 2003
Muniz Viviane P, Silva Helga C A, Tsanaclis Ana Maria C, Vainzof Mariz
Abstract excerpt
Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic predisposition associated with a susceptibility to volatile anesthetics and depolarizing muscle relaxants that lead to a fulminant anesthetic crisis with hyperthermia, skeletal muscle rigidity, respiratory and metabolic acidosis, and muscle rhabdomyolysis. Malignant hyperthermia crises are caused by an abnormal regulation of the calcium release...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
